Report: FDA on verge of authorizing Pfizer vaccine for ages 12 to 15
The Food and Drug Administration is expected to approve the use of Pfizer's coronavirus vaccine on 12- to 15-year-olds within days, possibly as early as this week, ABC7 NY reported Monday, citing health experts. Pfizer has said clinical trials show the COVID-19 vaccine it developed with BioNTech to be 100 percent effective in this age group. The vaccine already has been approved for people aged 16 and up. If regulators grant emergency approval, early teens could start getting vaccinated as soon as late May, setting the stage for many middle schoolers and young high-school students to be vaccinated before the next school year. [ABC7 NY]